Natalia Sjardin1, Peter Reed2, Ben Albert3, Fran Mouat4, Phillipa J Carter4, Paul Hofman3, Wayne Cutfield3, Alistair Gunn5, Craig Jefferies4. 1. Department of Paediatrics and Physiology, University of Auckland, Auckland, New Zealand. 2. Research Office, Auckland District Health Board, Auckland, New Zealand. 3. Liggins Institute, University of Auckland, Auckland, New Zealand. 4. Auckland District Health Board, Starship Children's Hospital, Auckland, New Zealand. 5. Faculty of Medical Health Sciences, University of Auckland, Auckland, New Zealand.
Abstract
AIM: It is important to understand whether type 2 diabetes mellitus (T2DM) is increasing in childhood for health-care planning and clinical management. The aim of this study is to examine the incidence of T2DM in New Zealand children, aged <15 years from a paediatric diabetes centre, Auckland, New Zealand. METHODS: Retrospective analysis of prospectively collected data from a population-based referral cohort from 1995 to 2015. RESULTS: Hundred and four children presented with T2DM over the 21-year period. The female:male ratio was 1.8:1, at mean (standard deviation) age 12.9 (1.9) years, body mass index standard deviation score +2.3 (0.5), blood sugar 15.3 (8.5) mmol/L, HbA1c 76 (28) mmol/mol. At diagnosis, 90% had acanthosis nigricans and 48% were symptomatic. In all, 33% were Maori, 46% Pacific Island, 15% Asian/Middle Eastern and 6% European. There was a progressive secular increase of 5% year on year in incidence. The overall annual incidence of T2DM <15 years of age was 1.5/100 000 (1.2-1.9) (95% confidence interval), with higher rates in Pacific Island (5.9/100 000) and Maori (4.1/100 000). CONCLUSIONS: The incidence of T2DM in children <15 years of age in New Zealand has increased progressively at 5%/year over the last 21 years. The risk was disproportionately associated with girls and children from high-risk ethnic groups.
AIM: It is important to understand whether type 2 diabetes mellitus (T2DM) is increasing in childhood for health-care planning and clinical management. The aim of this study is to examine the incidence of T2DM in New Zealand children, aged <15 years from a paediatric diabetes centre, Auckland, New Zealand. METHODS: Retrospective analysis of prospectively collected data from a population-based referral cohort from 1995 to 2015. RESULTS: Hundred and four children presented with T2DM over the 21-year period. The female:male ratio was 1.8:1, at mean (standard deviation) age 12.9 (1.9) years, body mass index standard deviation score +2.3 (0.5), blood sugar 15.3 (8.5) mmol/L, HbA1c 76 (28) mmol/mol. At diagnosis, 90% had acanthosis nigricans and 48% were symptomatic. In all, 33% were Maori, 46% Pacific Island, 15% Asian/Middle Eastern and 6% European. There was a progressive secular increase of 5% year on year in incidence. The overall annual incidence of T2DM <15 years of age was 1.5/100 000 (1.2-1.9) (95% confidence interval), with higher rates in Pacific Island (5.9/100 000) and Maori (4.1/100 000). CONCLUSIONS: The incidence of T2DM in children <15 years of age in New Zealand has increased progressively at 5%/year over the last 21 years. The risk was disproportionately associated with girls and children from high-risk ethnic groups.
Authors: Steven James; Jayanthi Maniam; Pik-To Cheung; Tatsuhiko Urakami; Julia von Oettingen; Supawadee Likitmaskul; Graham Ogle Journal: World J Clin Pediatr Date: 2022-03-09
Authors: Karen S W Leong; Thilini N Jayasinghe; Brooke C Wilson; José G B Derraik; Benjamin B Albert; Valentina Chiavaroli; Darren M Svirskis; Kathryn L Beck; Cathryn A Conlon; Yannan Jiang; William Schierding; Tommi Vatanen; David J Holland; Justin M O'Sullivan; Wayne S Cutfield Journal: Sci Rep Date: 2020-11-18 Impact factor: 4.379